Qualigen Therapeutics, Inc.
US ˙ NasdaqCM ˙ US74754R2022
이 기호는 더 이상 활성화되지 않습니다.

SecurityQLGN / Qualigen Therapeutics, Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership501 shares
Latest Disclosed Value $ 626
BlackRock, Inc. ownership in QLGN / Qualigen Therapeutics, Inc.

On May 13, 2026 - BlackRock, Inc. filed a 13F-HR form disclosing ownership of 501 shares of Qualigen Therapeutics, Inc. (US:QLGN) valued at $626 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 501 shares of Qualigen Therapeutics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $1,608 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F AIXCRYPTO HOLDINGS COM 74754R301 501 0 0.00 1 -100.00 0.0000
2026-02-12 2025-12-31 13F AIXCRYPTO HOLDINGS COM 74754R301 501 0 0.00 1 -50.00 0.0000
2025-11-12 2025-09-30 13F QUALIGEN THERAPEUTICS COM 74754R301 501 -10 -1.96 3 100.00 0.0000
2025-08-12 2025-06-30 13F QUALIGEN THERAPEUTICS COM 74754R301 511 0 0.00 2 0.00 0.0000
2025-05-02 2025-03-31 13F QUALIGEN THERAPEUTICS COM 74754R301 511 0 0.00 2 -50.00 0.0000
2025-02-07 2024-12-31 13F QUALIGEN THERAPEUTICS COM 74754R301 511 511 2 0.0000
2022-11-14 2022-09-30 13F QUALIGEN THERAPEUTICS COM 74754R103 258,419 0 0.00 69 -53.06 0.0000
2022-08-12 2022-06-30 13F QUALIGEN THERAPEUTICS COM 74754R103 258,419 -76,256 -22.79 147 -33.48 0.0000
2022-05-12 2022-03-31 13F QUALIGEN THERAPEUTICS COM 74754R103 334,675 9,632 2.96 221 -36.31 0.0000
2022-02-10 2021-12-31 13F QUALIGEN THERAPEUTICS COM 74754R103 325,043 -6,730 -2.03 347 -19.68 0.0000
2021-11-09 2021-09-30 13F QUALIGEN THERAPEUTICS COM 74754R103 331,773 -1,632 -0.49 432 -34.94 0.0000
2021-08-11 2021-06-30 13F QUALIGEN THERAPEUTICS COM 74754R103 333,405 15,587 4.90 664 -22.70 0.0000
2021-05-07 2021-03-31 13F QUALIGEN THERAPEUTICS COM 74754R103 317,818 0 0.00 859 -10.24 0.0000
2021-02-05 2020-12-31 13F QUALIGEN THERAPEUTICS COM 74754R103 317,818 3,692 1.18 957 -38.46 0.0000
2020-11-06 2020-09-30 13F QUALIGEN THERAPEUTICS COM 74754R103 314,126 313,548 54,247.06 1,555 77,650.00 0.0001
2020-08-14 2020-06-30 13F QUALIGEN THERAPEUTICS COM 74754R103 578 -14,503 -96.17 2 -50.00 0.0000
2020-05-01 2020-03-31 13F RITTER PHARMACEUTICALS COM NEW 767836307 15,081 1,140 8.18 4 100.00 0.0000
2020-02-13 2019-12-31 13F RITTER PHARMACEUTICALS COM NEW 767836307 13,941 258 1.89 2 -50.00 0.0000
2019-11-08 2019-09-30 13F RITTER PHARMACEUTICALS COM NEW 767836307 13,683 826 6.42 4 -71.43 0.0000
2019-08-22 2019-06-30 13F/A-1 RITTER PHARMACEUTICALS COM NEW 767836307 12,857 1,126 9.60 14 40.00 0.0000
2019-08-13 2019-06-30 13F RITTER PHARMACEUTICALS COM NEW 767836307 12,857 1,126 14
2019-05-09 2019-03-31 13F RITTER PHARMACEUTICALS COM NEW 767836307 11,731 409 3.61 10 66.67 0.0000
2019-02-08 2018-12-31 13F RITTER PHARMACEUTICALS COM NEW 767836307 11,322 684 6.43 6 -70.00 0.0000
2018-11-09 2018-09-30 13F RITTER PHARMACEUTICALS COM NEW 767836307 10,638 1,305 13.98 20 -16.67 0.0000
2018-08-09 2018-06-30 13F RITTER PHARMACEUTICALS COM NEW 767836307 9,333 712 8.26 24 4.35 0.0000
2018-05-09 2018-03-31 13F RITTER PHARMACEUTICALS COM NEW 767836307 8,621 -74,298 -89.60 23 -14.81 0.0000
2018-02-09 2017-12-31 13F RITTER PHARMACEUTICALS COM 767836109 82,919 4,720 6.04 27 0.00 0.0000
2017-11-14 2017-09-30 13F RITTER PHARMACEUTICALS COM 767836109 78,199 7,980 11.36 27 -30.77 0.0000
2017-08-10 2017-06-30 13F RITTER PHARMACEUTICALS COM 767836109 70,219 10,160 16.92 39 -54.12 0.0000
2017-05-12 2017-03-31 13F RITTER PHARMACEUTICALS COM 767836109 60,059 60,059 85 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.